Dr Laura Waters talk on HIV treatment cascade and other HIV population prevention/treatment issues.
2020 goals aiming for 90% of people with HIV diagnosed/90% diagnosed on treatment/90% on treatment undetectable - corresponds to 74% of those with HIV having undetectable viral load.
- Currently (globally) only 32% of those with HIV are on treatment with undetectable VL.
June 2016 paper (Lazarus et al) on adding a “fourth 90” to the 90-90-90-90 targets; that 90% of those on ARVs with undetectable VL have good health-related quality-of-life. Especially pertinent considering incidence of co-morbidities and ageing HIV-infected population (in developed countries).
2016 research from Toronto (Wilton et al) on high-risk populations and perception of risk studied 420 MSM who were objectively high risk:
- 68.3% didn’t perceive themselves to be at moderate to high risk
- 23.6% unaware of PrEP
- 40.1% unwilling to use prep
- 47% lacked a family physician with whom they could discuss HIV issues
Survey of Glasgow2016 audience on new directions for treatment - 40% of attendees believe that non-oral ART will be first-line by 2026.
Transmitted drug resistance by geographical region (START trial) - Australia highest (17.5% had any transmitted drug resistance)